Class II
Terminated
MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA
Why: cGMP deviations: Temperature abuse
- Company
- Mckesson Medical-Surgical Inc. Corporate Office
Richmond, VA, United States - Reported
- Jun 15, 2022
- Recall started
- Apr 13, 2022
- Ended
- Nov 30, 2023
- Where sold
- USA nationwide.
- Amount
- 983 cartons/1 vial each and 107 cartons/25 vials each
- Full product description
- MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA
- Lots / codes affected
- McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.